Literature DB >> 18704303

The effect of Gankang Suppository on duck hepatitis B virus, serum biochemistry and liver histology in ducklings.

Hui Li1, Deying Tian, Huiling Wu, Miao Chen, Anqun Chen.   

Abstract

To examine the effect of Gankang Suppository on duck hepatitis B virus (DHBV), the serum biochemistry and hepatic histology in an animal model of DHBV infection, a model of DHBV infection was established by infecting 1-day-old Yingtaogu ducklings with DHBV-positive serum. The successful model was confirmed by PCR assay and 48 ducklings infected with DHBV were randomly divided into 3 groups: a Gankang Suppository treatment group, an acyclovir (ACV) group and a DHBV model group (control), with each group having 16 animals. All the animals were given the medicines for 4 weeks in a row. The serum of the animals was taken 14 and 28 days after the medication and 7 days after drug discontinuation. Real-time PCR was performed to detect the copy numbers of DHBV DNA in the serum. ALT and AST were dynamically monitored. The ducklings were sacrificed on the 7th day after the discontinuation of the treatment and livers were harvested and examined for inflammation and degeneration of liver cells by using HE staining. The results showed that on day 14, 28 after the treatment and day 7 after the withdrawal, the logarithmic values (log) of DHBV DNA copy numbers in ducklings of Gankang Suppository treatment group were significantly lower than that before the treatment (P=0.0092, P=0.0070, P=0.0080, respectively). Compared with DHBV model control group, the ALT level was significantly decreased (P=0.0020, P=0.0019, respectively) on day 28 after the treatment and on day 7 after the withdrawal. The AST level was also reduced on day 14 after the treatment (P=0.0298). Compared with the ACV control group, the level of ALT was lower on day 7 after the withdrawal (P=0.0016). Histologically, the hepatocyte swelling, vacuolous degeneration and acidophilic degeneration in Gankang Suppository treatment group were alleviated 7 days after the withdrawal as compared with model control group (P=0.0282, P=0.0084, P=0.0195, respectively). It is concluded that Gankang Suppository can effectively suppress DHBV replication, reduce the levels of serum ALT and AST and improve hepatic histology.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18704303     DOI: 10.1007/s11596-008-0410-4

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  14 in total

1.  Chronic hepatitis B.

Authors:  Anna S F Lok
Journal:  N Engl J Med       Date:  2002-05-30       Impact factor: 91.245

2.  Viral clearance without destruction of infected cells during acute HBV infection.

Authors:  L G Guidotti; R Rochford; J Chung; M Shapiro; R Purcell; F V Chisari
Journal:  Science       Date:  1999-04-30       Impact factor: 47.728

3.  Glycyrrhizin inhibits the lytic pathway of complement--possible mechanism of its anti-inflammatory effect on liver cells in viral hepatitis.

Authors:  Y Fujisawa; M Sakamoto; M Matsushita; T Fujita; K Nishioka
Journal:  Microbiol Immunol       Date:  2000       Impact factor: 1.955

4.  Inhibition of human complement by beta-glycyrrhetinic acid.

Authors:  B H Kroes; C J Beukelman; A J van den Berg; G J Wolbink; H van Dijk; R P Labadie
Journal:  Immunology       Date:  1997-01       Impact factor: 7.397

5.  [Anti-hepatitis B virus effects of lamivudine and other five drugs in vitro].

Authors:  H Cao; P Tao
Journal:  Zhonghua Yi Xue Za Zhi       Date:  2001-08-25

6.  Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms.

Authors:  G J Webster; S Reignat; M K Maini; S A Whalley; G S Ogg; A King; D Brown; P L Amlot; R Williams; D Vergani; G M Dusheiko; A Bertoletti
Journal:  Hepatology       Date:  2000-11       Impact factor: 17.425

7.  [Experimental study of shuangcao granule no. 1 on duck hepatitis B virus in ducklings].

Authors:  Y Lian; J Tan; Z Deng
Journal:  Zhongguo Zhong Xi Yi Jie He Za Zhi       Date:  2000-07

8.  Long-term treatment of chronic hepatitis C with glycyrrhizin [stronger neo-minophagen C (SNMC)] for preventing liver cirrhosis and hepatocellular carcinoma.

Authors:  Hiromitsu Kumada
Journal:  Oncology       Date:  2002       Impact factor: 2.935

9.  Novel approach to quantitative polymerase chain reaction using real-time detection: application to the detection of gene amplification in breast cancer.

Authors:  I Bièche; M Olivi; M H Champème; D Vidaud; R Lidereau; M Vidaud
Journal:  Int J Cancer       Date:  1998-11-23       Impact factor: 7.396

10.  Effects of Phyllanthus plant extracts on duck hepatitis B virus in vitro and in vivo.

Authors:  A Shead; K Vickery; A Pajkos; R Medhurst; J Freiman; R Dixon; Y Cossart
Journal:  Antiviral Res       Date:  1992-06       Impact factor: 5.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.